Hot Investor Mandate: California VC Invests Up to $10M in Novel Life Science Technologies with Special Interests in Platform Therapeutics and Digital Health

21 Nov

A venture capital firm based in California firm invests globally across industries from two active funds, one that is investing primarily in Series A and B rounds, and the other fund is investing in growth stage opportunities. The firm is usually an active lead investor, but may also invest as part of broader syndicates. Typical Series A investments are $5-10M up front with additional capital reserved. The firm supports portfolio companies through entrepreneurial experience, network, and recruiting.

The firm has a strategic focus in life sciences and digital health. Special interest areas include therapeutics (especially platform technologies), digital health (especially products that improve health outcomes), and novel applications of transformative technologies (such as genomics and synthetic biology).

The firm believes passionately that their role is to support and serve great management teams and entrepreneurs.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: